Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.

Mohammad Ebrahimkhani 1 Fiona Oakley 2 Lindsay Murphy 2 Jelena Mann 2 Anna Moles 2 Maria Perugorria 2 Elizabeth Ellis 2 Anne Lakey 2 Alastair Burt 2 Angela Douglass 2 Matthew Wright 2 Steven White 2 Fabrice Jaffré 3 Luc Maroteaux 3 Derek Mann 2, *
* Auteur correspondant
1 Department of Biological engineering, Department of Biology
2 Fibrosis Laboratory, Liver Group
3 Institut du Fer à Moulin
Abstract : Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood. Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT(2B)) on HSCs by serotonin, which activates expression of transforming growth factor β1 (TGF-β1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT(2B) enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT(2B) or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT(2B) attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT(2B) is clinically safe in humans and may be therapeutic in chronic liver disease.
Type de document :
Article dans une revue
Nature Medicine, Nature Publishing Group, 2011, 17 (12), pp.1668-73. 〈10.1038/nm.2490〉
Liste complète des métadonnées

Littérature citée [27 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00652584
Contributeur : Luc Maroteaux <>
Soumis le : mercredi 30 mai 2012 - 16:47:52
Dernière modification le : vendredi 31 août 2018 - 08:46:10
Document(s) archivé(s) le : vendredi 31 août 2012 - 02:16:32

Fichier

Ebrahimkhani_200611.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

UPMC | IFM

Citation

Mohammad Ebrahimkhani, Fiona Oakley, Lindsay Murphy, Jelena Mann, Anna Moles, et al.. Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.. Nature Medicine, Nature Publishing Group, 2011, 17 (12), pp.1668-73. 〈10.1038/nm.2490〉. 〈inserm-00652584〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

482

Téléchargements de fichiers

373

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD